Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia 5Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Blast Crisis 2Neutropenia 1Leukemia, Myeloid, Acute 1Anemia, Refractory 1

Interventions

Arsenic Trioxide 21Tretinoin 20Cytarabine 12Cyclophosphamide 11Busulfan 10Methotrexate 9Idarubicin 9Filgrastim 8fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 6Tacrolimus 5Gemtuzumab 5Etoposide 5Radiotherapy 4Clofarabine 4Antilymphocyte Serum 4Topotecan 3Mycophenolic Acid 3Mitoxantrone 3Mercaptopurine 3Daunorubicin 3venetoclax 2lintuzumab 2Whole-Body Irradiation 2Thiotepa 2Sorafenib 2Granulocyte Colony-Stimulating Factor 2Cyclosporins 2Cyclosporine 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Promyelocytic, Acute × lintuzumab × Clear all
NCT00002609 2013-06-24

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00016159 2013-01-16

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
35 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡